help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Avizienyte, E.
Right arrow Articles by Aaltonen, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Avizienyte, E.
Right arrow Articles by Aaltonen, L. A.
(American Journal of Pathology. 1999;154:677-681.)
© 1999 American Society for Investigative Pathology


Short Communication

LKB1 Somatic Mutations in Sporadic Tumors

Egle Avizienyte* , Anu Loukola* , Stina Roth* , Akseli Hemminki* , Maija Tarkkanen* , Reijo Salovaara*{dagger} , Johanna Arola{dagger} , Ralf Bützow{dagger} , Kirsti Husgafvel-Pursiainen{ddagger} , Arto Kokkola§ , Heikki Järvinen§ and Lauri A. Aaltonen*

From the Departments of Medical Genetics* and Pathology,{dagger} Haartman Institute, University of Helsinki, the Finnish Institute of Occupational Health,{ddagger} and the Second Department of Surgery,§ Helsinki University Central Hospital, Helsinki, Finland

Germline mutations of LKB1/Peutz-Jeghers syndrome gene predispose carriers to hamartomatous polyposis of the gastrointestinal tract as well as to cancer of different organ systems. Although Peutz-Jeghers syndrome patients frequently present with neoplasms of the colon, stomach, small intestine, pancreas, breast, ovaries, and cervix, somatic mutations appear to be rare in the sporadic tumor types thus far studied (colorectal, gastric, testicular, and breast cancers). To evaluate whether somatic mutations of LKB1 contribute to the tumorigenesis of yet unstudied tumor types, we screened 14 cell lines and 129 tumor specimens from different cancers for a genetic defect in LKB1. Six melanoma and eight myeloma cell lines were scrutinized for LKB1 somatic mutations by genomic sequencing. No changes were found in the coding LKB1 sequence and exon/intron boundaries. Next, we analyzed 12 pancreatic, 8 gastric, 12 ovarian granulosa cell, 26 cervical, 28 lung, 24 soft tissue, and 19 renal tumors by single-strand conformational polymorphism analysis. Three changes in LKB1 coding nucleotide sequence were identified. One base pair deletion at A957 and G958 substitution by T occurred in a cervical adenocarcinoma sample, resulting in a frameshift and premature stop codon at position 335. Substitution of A581 by T occurred in a lung adenocarcinoma sample, resulting in the change of aspartic acid at position 194 to valine. A loss of another allele was detected in this sample. One silent change, C1257T, was found in a pancreatic carcinoma sample. The changes were not present in the matched normal tissue DNA samples. Our results suggest that mutational inactivation of LKB1 is a rare event in most sporadic tumor types.





This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
K. H. Lu, W. Wu, B. Dave, B. M. Slomovitz, T. W. Burke, M. F. Munsell, R. R. Broaddus, and C. L. Walker
Loss of Tuberous Sclerosis Complex-2 Function and Activation of Mammalian Target of Rapamycin Signaling in Endometrial Carcinoma
Clin. Cancer Res., May 1, 2008; 14(9): 2543 - 2550.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
D. W. Kim, H. K. Chung, K. C. Park, J. H. Hwang, Y. S. Jo, J. Chung, D. V. Kalvakolanu, N. Resta, and M. Shong
Tumor Suppressor LKB1 Inhibits Activation of Signal Transducer and Activator of Transcription 3 (STAT3) by Thyroid Oncogenic Tyrosine Kinase Rearranged in Transformation (RET)/Papillary Thyroid Carcinoma (PTC)
Mol. Endocrinol., December 1, 2007; 21(12): 3039 - 3049.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. D. Scott, S. Nath-Sain, M. D. Agnew, and P. A. Marignani
LKB1 Catalytically Deficient Mutants Enhance Cyclin D1 Expression
Cancer Res., June 15, 2007; 67(12): 5622 - 5627.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. M. Wagner, J. E. Mullally, and F. A. Fitzpatrick
Reactive Lipid Species from Cyclooxygenase-2 Inactivate Tumor Suppressor LKB1/STK11: CYCLOPENTENONE PROSTAGLANDINS AND 4-HYDROXY-2-NONENAL COVALENTLY MODIFY AND INHIBIT THE AMP-KINASE KINASE THAT MODULATES CELLULAR ENERGY HOMEOSTASIS AND PROTEIN TRANSLATION
J. Biol. Chem., February 3, 2006; 281(5): 2598 - 2604.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. Ghaffar, F. Sahin, M. Sanchez-Cepedes, G. H. Su, M. Zahurak, D. Sidransky, and W. H. Westra
LKB1 Protein Expression in the Evolution of Glandular Neoplasia of the Lung
Clin. Cancer Res., August 1, 2003; 9(8): 2998 - 3003.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. I. Jimenez, P. Fernandez, O. Dominguez, A. Dopazo, and M. Sanchez-Cespedes
Growth and Molecular Profile of Lung Cancer Cells Expressing Ectopic LKB1: Down-Regulation of the Phosphatidylinositol 3'-Phosphate Kinase/PTEN Pathway
Cancer Res., March 15, 2003; 63(6): 1382 - 1388.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Sanchez-Cespedes, P. Parrella, M. Esteller, S. Nomoto, B. Trink, J. M. Engles, W. H. Westra, J. G. Herman, and D. Sidransky
Inactivation of LKB1/STK11 Is a Common Event in Adenocarcinomas of the Lung
Cancer Res., July 1, 2002; 62(13): 3659 - 3662.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
M M Entius, J J Keller, A M Westerman, B P van Rees, M-L F van Velthuysen, A F P M de Goeij, J H P Wilson, F M Giardiello, and G J A Offerhaus
Molecular genetic alterations in hamartomatous polyps and carcinomas of patients with Peutz-Jeghers syndrome
J. Clin. Pathol., February 1, 2001; 54(2): 126 - 131.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
L F Forster, S Defres, D R Goudie, D U Baty, and F A Carey
An investigation of the Peutz-Jeghers gene (LKB1) in sporadic breast and colon cancers
J. Clin. Pathol., October 1, 2000; 53(10): 791 - 793.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
J Trojan, A Brieger, J Raedle, M Esteller, and S Zeuzem
5'-CpG island methylation of the LKB1/STK11 promoter and allelic loss at chromosome 19p13.3 in sporadic colorectal cancer
Gut, August 1, 2000; 47(2): 272 - 276.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. Launonen, E. Avizienyte, A. Loukola, P. Laiho, R. Salovaara, H. Järvinen, J.-P. Mecklin, A. Oku, M. Shimane, H. C. Kim, et al.
No Evidence of Peutz-Jeghers Syndrome Gene LKB1 Involvement in Left-sided Colorectal Carcinomas
Cancer Res., February 1, 2000; 60(3): 546 - 548.
[Abstract] [Full Text]


Home page
J. Med. Genet.Home page
R. W. CHEN, E. AVIZIENYTE, S. ROTH, I. LEIVO, A. A MAKITIE, L.-M. AALTONEN, and L. A AALTONEN
PTEN and LKB1 genes in laryngeal tumours
J. Med. Genet., December 1, 1999; 36(12): 943 - 944.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Tiainen, A. Ylikorkala, and T. P. Makela
Growth suppression by Lkb1 is mediated by a G1 cell cycle arrest
PNAS, August 3, 1999; 96(16): 9248 - 9251.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. A. Marignani, F. Kanai, and C. L. Carpenter
LKB1 Associates with Brg1 and Is Necessary for Brg1-induced Growth Arrest
J. Biol. Chem., August 24, 2001; 276(35): 32415 - 32418.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Society for Investigative Pathology.